|
ZNF331 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.676780E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.182600E-03 |
| Normal-vs-Stage2 |
1.799670E-02 |
| Normal-vs-Stage3 |
4.633000E-04 |
| Normal-vs-Stage4 |
8.562900E-04 |
| Stage1-vs-Stage2 |
4.410200E-01 |
| Stage1-vs-Stage3 |
1.629510E-02 |
| Stage1-vs-Stage4 |
1.867220E-01 |
| Stage2-vs-Stage3 |
1.095590E-01 |
| Stage2-vs-Stage4 |
1.940210E-01 |
| Stage3-vs-Stage4 |
5.128200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.960910E-03 |
| Normal-vs-AfricanAmerican |
1.042030E-01 |
| Normal-vs-Asian |
1.520840E-03 |
| Caucasian-vs-AfricanAmerican |
1.948370E-01 |
| Caucasian-vs-Asian |
6.282200E-01 |
| AfricanAmerican-vs-Asian |
1.561360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.967600E-04 |
| Normal-vs-Female |
2.278300E-03 |
| Male-vs-Female |
7.738400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.340600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.196500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.257540E-03 |
| Normal-vs-Age(81-100Yrs) |
9.768000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.249400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.885400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.782600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.170600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.409420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.727170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.011960E-02 |
| Classical-VS-Follicular |
3.279900E-03 |
| Classical-VS-Other |
8.752400E-01 |
| Classical-VS-Normal |
3.596900E-03 |
| Tall-VS-Follicular |
3.397000E-01 |
| Tall-VS-Other |
2.133600E-01 |
| Tall-VS-Normal |
3.216800E-04 |
| Follicular-VS-Other |
2.782000E-01 |
| Follicular-VS-Normal |
5.635300E-04 |
| Other-VS-Normal |
5.964200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.999400E-04 |
| Normal-vs-N1 |
8.426500E-04 |
| N0-vs-N1 |
7.397800E-01 |
|
|
